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Abstract: Aflatoxin B1 (AFB1) is a potent carcinogen that causes growth stunting, 
immunosuppression and liver cancer in multiple species. The recent trend of replacing 
fishmeal with plant-based proteins in fish feed has amplified the AFB1 exposure risk in 
farm-raised fish. NovaSil (NS), a calcium montmorillonite clay, has previously been 
shown to reduce AFB1 bioavailability safely and efficaciously in several mammalian 
species. This study was designed to: (1) evaluate AFB1 impact on cultured red drum, 
Sciaenops ocellatus, over the course of seven weeks; and (2) assess NS supplementation as 
a strategy to prevent aflatoxicosis. Fish were fed diets containing 0, 0.1, 0.25, 0.5, 1, 2, 3, 
or 5 ppm AFB1. Two additional treatment groups were fed either 5 ppm AFB1 + 1% NS or 
5 ppm AFB1 + 2% NS. Aflatoxin B1 negatively impacted red drum weight gain, survival, 
feed efficiency, serum lysozyme concentration, hepatosomatic index (HSI), whole-body 
lipid levels, liver histopathological scoring, as well as trypsin inhibition. NovaSil inclusion 
in AFB1-contaminated diets improved weight gain, feed efficiency, serum lysozyme 
concentration, muscle somatic index, and intraperitoneal fat ratios compared to  
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AFB1-treated fish. Although not significant, NS reduced AFB1-induced histopathological 
changes in the liver and decreased Proliferating Cell Nuclear Antigen (PCNA) staining. 
Importantly, NS supplementation improved overall health of AFB1-exposed red drum. 
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1. Introduction 
Mycotoxins are toxic metabolites produced by a diverse group of fungi that contaminate 
agricultural crops prior to harvest or during storage post-harvest [1,2]. Aflatoxin B1 (AFB1),  
a mycotoxin produced by Aspergillus flavus and A. parasiticus, is one of the most potent,  
naturally-occurring carcinogens known to mankind. Aflatoxin B1 exposure causes decreases in weight 
gain, growth stunting and immunosuppression in animals, while increasing hepatocellular carcinoma 
incidence [3]. Different species including humans, poultry, swine, and fish all exhibit varying levels of 
mortality and morbidity upon exposure to AFB1 [4–6]. However, because the damaging AFB1 effects 
are largely species and dose-specific, additional studies are necessary to determine AFB1 susceptibility 
for at-risk unevaluated species. 
As a vital part of the global food industry, aquaculture contributes nearly half of all food of aquatic 
origin intended for human consumption [7]. Fishmeal, one the most expensive fish feed ingredients, is 
widely used in the aquaculture industry as the major protein source for farm-raised fish [8]. Menhaden 
(Brevoortia sp.) is a clupeid fish species and the most prevalent form of fishmeal used in North 
America [9]. Recent studies have been directed toward the development of plant-based alternative 
protein sources such as soybean, peanut, corn and cottonseed meal [10–13]. However, incorporation of 
plant-based ingredients into feed increases the risk for AFB1 contamination and subsequent exposure. 
Aflatoxin B1 presence in aquaculture feeds and fish feed ingredients has been well-documented, 
especially in developing countries [14–16]. 
One strategy to reduce aflatoxin exposure in humans and animals is the use of enterosorption 
therapy. NovaSil (NS), a calcium montmorillonite clay, binds AFB1 in the gastrointestinal tract, 
thereby reducing overall AFB1 bioavailability [17]. With a dioctahedral-layered structure and 
negatively charged interlayer, NS has high affinity and capacity for AFB1 molecules, which exhibit a 
partial positive charge [18]. Numerous in vivo studies have demonstrated the safety and efficacy of this 
technology [19–21], although additional studies are needed to determine the efficacy and proper 
dosage for farm-raised fish [22]. 
Red drum, Sciaenops ocellatus, is a common recreational and commercial fish native to the Atlantic 
and Gulf Coast regions of the United States [23]. Red drum is currently farmed in China, Israel, 
Ecuador and North America [24]. Despite its prevalence and economic importance to the food 
industry, no studies have evaluated red drum AFB1 susceptibility. The study presented here was 
designed to address two objectives: (1) to evaluate red drum susceptibility to AFB1 using a multi-level 
AFB1 challenge incorporated into the feed; and (2) to assess the ability of NS to prevent AFB1 toxicity 
in red drum. 




2.1. Growth Parameters 
Aflatoxin B1 treatment effects, including weight gain (%), survival (%), and feed efficiency, did not 
result in linear trends, with R2 values of 0.22, 0.01 and 0.1, respectively. Weight gain of individual 
treatment means were significantly different, and varied with the 0 ppm AFB1 group experiencing the 
highest weight gain and the 2, 3, and 5 ppm exposure groups exhibiting the least amount of weight 
gain (Table 1). Likewise, AFB1 significantly reduced feed efficiency in a non-linear manner, with the  
0 ppm AFB1 treatment group demonstrating the highest feed efficiency (0.91) and treated groups 
ranging from 0.49–0.75. Survival also greatly varied across treatments with 0 ppm AFB1 having the 
highest survival rate. 
Among the NS-supplemented treatment groups, only weight gain and feed efficiency were 
significantly different compared to AFB1 controls, with p-values of 0.039 and 0.005, respectively. In 
the case of feed efficiency, 0 ppm AFB1 and 5 ppm AFB1 were the most significantly different. 
NovaSil inclusion at both 1% and 2% positively affected weight gain, feed efficiency, and survival 
after AFB1 exposure, although not in a dose-dependent manner. 
2.2. Immune Response 
A summary of immune parameters evaluated for each group is shown in Table 2. The 0.1 ppm 
AFB1-exposed fish exhibited the highest plasma lysozyme values (246 units/mL), while the  
5 ppm-exposed fish displayed the lowest levels (45 units/mL). Trypsin inhibition (%) results indicated 
that 1, 2, 3, and 5 ppm AFB1-exposed groups had the lowest percent inhibition and 0.25 ppm AFB1 the 
highest. Additionally, neither the lysozyme nor the trypsin results suggested linearity with an R2 of 
0.3947 and 0.109, respectively. The nitro blue tetrazolium (NBT) test showed no significant 
differences among any of the AFB1-exposed groups. 
NovaSil had a significant impact (p = 0.021) on the plasma lysozyme concentration with 5 ppm 
AFB1 + 2% NS outperforming all other treatments. NovaSil did not significantly alter levels of NBT or 
trypsin inhibition. 
2.3. Somatic Indexes 
Somatic indexes for spleen, MSI and IPF did not vary within the AFB1-treated groups; however, 
HSI varied slightly between treatments. The highest HSI levels were recorded in the 0.1 AFB1-treated 
group, while the 2 ppm and 5 ppm exposure groups exhibited the lowest values (Table 3). A linear 
trend was not present in any of the groups. 
In the NS-supplemented groups, muscle and IPF levels recovered to control levels in the treatment 
group administered 2% NS. Likewise, the means of main effect data indicate that NS inclusion at 
either 0% and 1% was statistically different than 2%. 
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Table 1. Growth performance of red drum fed different concentrations of Aflatoxin B1 (AFB1) 1 and AFB1 + NovaSil (NS) 2,3,4. 
Variable 





Variable Weight gain (%) Survival (%) Feed efficiency 
AFB1 (ppm) Individual treatment means AFB1 (ppm) NS (%) Individual treatment means 
0 332 a 80.0 a 0.91 a 0 0 332 ab 80.0 0.91 a 
0.1 223 bc 46.6 b 0.62 bc 5 0 188 c 55.5 0.62 c 
0.25 224 bc 55.5 b 0.65 bc 5 1 339 a 73.3 0.82 ab 
0.5 254 ab 60.0 ab 0.75 ab 5 2 218 bc 57.7 0.71 bc 
1 212 bc 60.0 ab 0.73 abc p-value  0.039 0.261 0.005 
2 136 c 60.0 ab 0.49 c Pooled Std. Error  7.047 1.801 0.008 
3 183 bc 62.2 ab 0.67 bc AFB1 (ppm) NS (%) Means of main effect 
5 188 bc 55.5 b 0.62 bc 0  332 80.0 0.91 a 
R2 0.229 0.010 0.100 5  249 62.2 0.72 b 
p-value 0.005 0.132 0.030  0 260 a 67.7 0.77 
Pooled Std. Error 5.189 1.309 0.013  1 339 ab 73.3 0.82 
     2 218 b 57.7 0.71 
      ANOVA: p-values 
    AFB1  0.083 0.138 0.003 
    NS  0.043 0.387 0.029 
1 Aflatoxin B1; 2 NovaSil; 3 Values are means of three replicate groups of fish (n = 3); 4 Values in a column that do not have the same superscript are significantly different 
according to Duncan’s multiple range test (p < 0.05); 5 Initial average weight was 2.1 ± 0.1 g/fish. 
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AFB1 (ppm) Individual treatment means AFB1 (ppm) NS (%) Individual treatment means 
0 165 ab 3.52 83.6 ab 0 0 165 ab 3.52 83.6 
0.1 246 a 3.35 82.4 b 5 0 45 c 3.07 81.9 
0.25 131 bcd 2.54 86.3 a 5 1 76b c 3.32 81.3 
0.5 155 abc 3.30 83.2 b 5 2 185 a 3.21 79.4 
1 106 bcd 1.78 81.9 b p-Value  0.024 0.944 0.577 
2 82 bcd 3.05 80.5 b Pooled Std. Error  5.550 0.104 0.395 
3 63 cd 2.21 82.7 b AFB1 (ppm) NS (%) Means of main effect 
5 45 d 3.07 81.9 b 0  165 3.52 83.6 
R2 0.394 0.015 0.109 5  102 3.20 80.9 
p-Value 0.004 0.250 0.038   0 105 3.30 82.7 
Pooled Std. Error 5.705 0.102 0.192  1 76 3.32 81.3 
     2 185 3.21 79.4 
      ANOVA: p-Values 
    AFB1 0.018 0.622 0.291 
    NS  0.021 0.948 0.674 
1 Values in a column that do not have the same superscript letters are significantly different according to Duncan’s multiple range test (p < 0.05); 2 Values are means of 
determinations on two fish from each of three replicate groups (6 fish/treatment, n = 6).  
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Table 3. Somatic indices of red drum fed different concentrations of AFB1 1 and AFB1 + NS 2,3,4. 
Variable Spleen MSI 5 HSI 6 IPF 7 Variable Spleen MSI 5 HSI 6 IPF 7 
AFB1 (ppm) Individual treatment means AFB1 (ppm) NS (%) Individual treatment means 
0 0.04 28.94 1.67 abc 0.32 0 0 0.04 28.94 a 1.67 0.32 a 
0.1 0.04 27.42 1.98 a 0.11 5 0 0.04 26.06 b 0.88 0.01 b 
0.25 0.04 26.18 1.79 ab 0.20 5 1 0.09 28.33 ab 0.82 0.10 b 
0.5 0.05 27.87 1.20 abc 0.26 5 2 0.20 29.70 a 1.56 0.46 a 
1 0.03 27.79 1.15 abc 0.07 p-Value  0.528 0.031 0.292 0.003 
2 0.18 26.25 0.72 c 0.18 Pooled Std. Error  0.015 0.135 0.070 0.012 
3 0.05 25.72 0.94 abc 0.06 AFB1 (ppm) NS (%) Means of main effect 
5 0.04 26.06 0.88 bc 0.01 0  0.04 28.94 1.67 0.32 
R2 0.004 0.141 0.267 0.152 5  0.11 28.03 1.09 0.19 
p-Value 0.503 0.417 0.091 0.466  0 0.04 27.50 1.27 0.17 a 
Pooled Std. Error 0.015 0.315 0.091 0.03  1 0.09 28.33 0.82 0.10 a 
  2 0.20 29.70 1.56 0.46 b 
   ANOVA: p-Values 
 AFB1  0.494 0.298 0.205 0.112 
 NS  0.429 0.019 0.332 0.002 
1 Aflatoxin B1; 2 NovaSil; 3 Values in a column that do not have the same superscript letters are significantly different according to Duncan’s multiple range test  
(p < 0.05); 4 Values are means of determinations on two fish from each of three replicate groups (6 fish/treatment, n = 6); 5 Muscle somatic index; 6 Hepatosomatic index;  
7 Intraperitoneal fat.  
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2.4. Proximate Composition 
No linear trends were present in the AFB1-treated groups (Table 4). Percent lipid composition was 
highest in the 0 ppm AFB1 group and the lowest at 2 ppm AFB1, but varied among other treatments. 
There were some variations in ash values as well; however, these results were not linearly correlated. 
Inclusion of NS in the diets did not exhibit any statistically significant changes in whole-body 
proximate composition. 

















AFB1 (ppm) Individual treatment means 
AFB1 
(ppm) 
NS (%) Individual treatment means 
0 2.70 a 76.01 78.38 16.38 ab 0 0 2.21 76.01 78.30 3.54 
0.1 2.37 ab 74.45 79.34 17.56 a 5 0 1.98 76.52 79.29 3.73 
0.25 1.97 bcd 70.06 79.67 13.64 b 5 1 2.20 73.92 76.91 4.28 
0.5 2.42 ab 74.33 77.69 16.72 ab 5 2 2.19 72.93 79.04 4.35 
1 2.17 abc 71.64 78.71 18.04 a p-Value  0.510 0.723 0.173 0.629 
2 1.45 d 74.20 84.55 19.43 a 
Pooled 
Std. Error
 0.022 0.488 0.140 0.098 
3 1.77 cd 71.64 80.60 17.22 a 
AFB1 
(ppm) 
NS (%) Means of main effect 
5 1.98 bcd 76.52 79.29 18.02 a 0  2.21 76.01 78.38 3.54 
R2 0.211 0.021 0.024 0.109 5  2.12 74.46 78.41 4.12 
p-Value 0.002 0.476 0.452 0.038  0 2.10 76.20 78.83 3.64 
Pooled Std. 
Error 
0.033 0.441 0.402 1.728  1 2.20 73.90 76.91 4.28 
  2 2.19 72.90 79.04 4.35 
   ANOVA: p-Values 
 AFB1  0.534 0.611 0.964 0.357 
 NS  0.394 0.604 0.095 0.663 
1 Values are means of determinations on three fish from each of the three replicates (n =3). 2 Values in a column that do 
not have the same superscript letters are significantly different according to Duncan’s multiple range test (p < 0.05). 
2.5. Histopathological Response and Immunohistochemistry 
Significant histological changes were observed between treatments (Table 5), with 3 and 5 ppm 
AFB1 eliciting the most severe hepatic alterations. Although some samples revealed significant hepatic 
lesions in groups treated with 5 ppm AFB1 + 1% or 2% NS, the findings in these fish were considered 
mild when compared to the 5 ppm AFB1 without NS. There were no significant differences in 
Proliferating Cell Nuclear Antigen (PCNA) values among all treatments, nor did PCNA staining 
exhibit a positive linear correlation. Histological changes, characterized by restoration of 
hepatocellular macrovacuolation and reduced megalocytosis and karyomegaly, were noted with the 
addition of NS in the diet; however, these results were not statistically significant (Figure 1). A 
decrease in PCNA staining as compared to the 5 ppm inclusion level was noted, but also did not 
achieve significant levels with 1% or 2% NS inclusion in the diet (Figure 2). 
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Table 5. Histopathology and immunohistochemistry. 




AFB1 (ppm) NS (%) 
Individual  
treatment means 
0 5.25 a 6.27 0 0 13.16 ab 6.27 
0.1 10.67 a 8.59 5 0 19.00 b 10.49 
0.25 17.33 ab 9.35 5 1 9.16 a 9.11 
0.5 30.16 c 11.34 5 2 7.66 a 9.72 
1 25.83 bc 9.52 p-Value  0.0925 0.7542 
2 31.83 c 9.06 Pooled Std. Error  0.838 0.836 
3 37.00 c 10.30 AFB1 (ppm) NS (%) Means of main effect 
5 37.00 c 10.49 0  13.16 6.27 
R2 0.2353 0.0204 5  11.94 9.78 
p-Value 0.0001 0.5059  0 16.08 8.38 
Pooled Std. Error 1.130 0.815  1 9.16 9.11 
  2 7.66 9.72 
   ANOVA: p-Values 
 AFB1  0.7248 0.3251 
 NS  0.0491 0.9454 
1 Values in a column that do not have the same superscript letters are significantly different according to 
Duncan’s multiple; range test (p < 0.05).  
3. Discussion 
Aflatoxin B1 displayed a significant effect across multiple treatment levels. The survival rate for the 
basal diet group (0 ppm AFB1) was similar to control survival results reported in other red drum 
studies [25,26], although survival was negatively affected by AFB1 presence. Likewise, the impact  
on feed efficiency and weight gain found in this study has been similarly documented in other  
AFB1-exposure publications, including research analyzing the effects of aflatoxins on several different 
farmed aquatic species [27–31]. The majority of AFB1-sensitive ichthyoids are cold-water species and 
our findings suggest that red drum may be one of the first identified AFB1-sensitive warm-water 
species. However additional studies are necessary to determine the specific metabolic mechanisms 
responsible for this sensitivity. 
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Figure 1. Liver histopathology in AFB1-exposed red drum. Liver sections were stained with hematoxylin and eosin. Treatments were as 
follows: (A) 0 ppm AFB1 (B) 1 ppm AFB1 (C) 3 ppm (D) 5 ppm AFB1 (E) AFB1 + 1% NS and (F) 5 ppm AFB1 + 2% NS. Marked 
pleomorphism, megalokaryosis with prominent nucleoli (arrows) and loss of hepatocellular cytoplasmic macrovacuolation was observed in 
the treatment groups that received large amounts of aflatoxin (B,C,D). Although not significant, inclusion of NS resulted in decreased 
histopathological scores attributable to increased cytoplasmic vacuolation and reduced cellular pleomorphism. 
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Figure 2. Proliferating Cell Nuclear Antigen (PCNA) positive cells in red drum hepatocytes. Liver sections were stained with PCNA (arrows) 
and hematoxylin counterstain. Treatments were as follows: (A) 0 ppm AFB1 (B) 1 ppm AFB1 (C) 3 ppm AFB1 (D) 5 ppm AFB1  
(E) 5 ppm AFB1 + 1% NS (F) 5 ppm AFB1 + 2% NS. Although not significant, inclusion of NS resulted in a decrease of PCNA-positive 
hepatocytes. Reduction in cell proliferation suggests that NS afforded some protection from AFB1 toxicity and cellular proliferation. 
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The published aquaculture literature indicates that incremental increases in AFB1 exposure do not 
typically result in dose-dependent, linear responses [32–34]. Herein, analysis of growth performance 
factors indicated that some of the most significant AFB1 effects were present at the lowest level of 
AFB1-exposure (0.1 ppm) for feed efficiency, survival, and weight gain. Hormetic responses for 
growth and immunological parameters have been observed in several species [35]. Hormesis is defined 
as a biphasic response to a xenobiotic, characterized by a low-dose stimulatory effect and high-dose 
inhibitory or toxic effect in which a U-shaped or J-shaped model is apparent [36]. Instances of  
AFB1-associated hormesis have also been documented in multiple species [32,37,38]. Several 
measured parameters in the current study suggest that AFB1-exposed red drum exhibited an “inverted 
U-shaped” immunological hormetic response to AFB1 as suggested by plasma lysozyme at the  
0.1 ppm level and trypsin inhibition at the 0.25 ppm level. Additionally, HSI results indicated a similar 
increase at the 0.1 ppm level followed by subsequent decreases at higher AFB1 levels. 
Several studies have indicated that PCNA is a suitable marker for cellular proliferation in  
fish [39,40] as well as other species [41,42]. However, our study did not indicate any significant 
differences in PCNA staining among the treatments. It is possible that the levels of AFB1 used in this 
study were not capable of inducing significant cellular proliferation as observed with other species. 
While there was a slight increase in PCNA with the presence of AFB1, there was a decrease in HSI. 
The increase in PCNA is due to liver damage and mitotic activity from AFB1-exposure, while the 
overall decrease in HSI is likely attributed to the loss of vacuolation and fat in the liver. Histological 
evaluation indicated liver changes characterized by anisokaryosis, megalocytosis and karyomegaly  
in AFB1-exposed red drum, which have been noted in a series of AFB1 studies with other fish  
species [43–45]. Hepatocellular lipid deposition, a well-documented classical sign of aflatoxicosis in 
fish [46,47], was present in red drum exposed to AFB1. However, red drum kept in captivity typically 
display fatty deposition and hepatocellular macrovacuolation [48], which should be taken into 
consideration for accurate red drum liver evaluation. The hepatocellular vacuolation seen in control 
livers was markedly reduced, as anisocytosis and karyomegaly increased, especially in fish exposed to 
higher levels of aflatoxin. Interestingly, hepatocellular vacuolation and liver fat were restored in fish 
treated with NS. Ideally, further red drum AFB1 studies should pair liver histological evaluation with 
other molecular markers to confirm liver damage, such as inducible nitric oxide synthase ([49] or  
γ-glutamyl transpeptidase [50,51]. Additionally, because feed efficiency, IPF and liver fat decreased 
with AFB1 exposure, it is possible that there was increased energy expenditure in these fish because 
less food was utilized. However, more research is needed to determine the exact mechanism of fat loss 
in AFB1-exposed red drum. 
In this study, NS supplementation in the diets of AFB1-exposed fish resulted in a protective effect, 
which was evident by the significant improvement in many of the tested parameters. Other studies 
have reported that a 2% inclusion level of bentonite, a common clay containing montmorillonite, in 
trout feed reduced toxic AFB1 effects [52]. Yet other studies suggest that a 0.5% inclusion level was 
sufficient to protect tilapia from 1.5 ppm AFB1 [45]. Bentonites have been added into fish feed at 
concentrations up to 10% with no alteration in whole-body proximate composition [53]. Discrepancies 
in the aquaculture literature concerning the proper inclusion level of clay-based binders indicate a need 
to establish a clay dosing regimen for fish at risk for AFB1 exposure. 
Toxins 2013, 5 1566 
 
 
4. Materials and Methods 
4.1. Experimental Diets 
The control basal diet was composed of 400 g protein kg−1 and 110 g lipid kg−1, containing an 
estimated 3.5 kcal digestible energy kg−1 (Table 6) and fulfilling all documented nutrient requirements 
of red drum [54]. Aflatoxin B1 (Sigma-Aldrich, St. Louis, MO, USA) was incorporated into the diet by 
first dissolving the AFB1 in chloroform and subsequently adding it to Celufil, a non-nutritive bulking 
agent (USB Corporation, Cleveland, OH, USA). The chloroform was evaporated to dryness from the 
mixture in a dark room under a fume hood, leaving the Celufil amended with AFB1. A  
V-mixer was used to blend all dry ingredients, with the exception of the AFB1-spiked Celufil, for  
20 min. The dry ingredients were then mixed with the AFB1-spiked Celufil in a Hobart mixer until 
homogeneity was achieved. The oil component and 700 mL of H2O were further added to the dry 
ingredients and mixed for 1 h. Aflatoxin-free Celufil was incorporated into the basal diet for 
comparison. The moist feed was cold-pelleted through a 3-mm die on a meat grinder attachment and 
dried in a dark room for 24 h. Diets were subsequently bagged and stored at −20 °C until needed. The 
ten diets contained the following: 0 ppm AFB1 (i.e., 0 ppm AFB1 + 0% NS), 0.1 ppm AFB1, 0.25 ppm 
AFB1, 0.5 ppm AFB1, 1 ppm AFB1, 2 ppm AFB1, 3 ppm AFB1, 5 ppm AFB1, 5 ppm AFB1 + 1% NS 
and 5 ppm AFB1 + 2% NS. A NS control group was not included since its safety was previously 
evaluated over the course of 10 weeks in a similar warm-water species [22]. 
4.2. Fish Stock and Culture Conditions 
Fingerling red drum were transported from the Texas Parks and Wildlife hatchery located at Lake 
Jackson, TX to the Texas A&M Aquacultural Research and Teaching Facility. Fish were stocked and 
conditioned in round tanks with a commercial diet (Rangen, Inc., Angelton, TX, USA) for 2 weeks, 
then transferred to aquaria and conditioned for 1 week on the basal diet. A closed, re-circulating 
system was composed of 110 L aquaria with water flowing at 1 L/min. Biofiltration was used to 
maintain ammonia, nitrate and nitrite concentrations at non-toxic levels. Salinity was maintained at  
7 ppt with artificial salts and water temperature was kept constant at 37 ± 2 °C by controlling air 
temperature in the wet laboratory. Supplemental aeration provided an adequate dissolved oxygen  
level of at least 80% air saturation. A 12:12 h light:dark cycle was maintained throughout the 
conditioning and trial period and water quality was monitored on a daily basis. Fifteen fish (2.1 ± 0.1 g) 
were stocked in each aquarium. The 10 dietary treatments were randomly assigned to triplicate 
aquaria, requiring a total of 30 tanks. Fish were fed a morning and afternoon ration over the course of 
7 weeks. The diets were fed to fish beginning at a rate of 6% of the initial body weight and tapered to 
3% over the span of the trial to prevent overfeeding and to approach apparent satiation. The system 
was monitored for mortalities and any deceased fish were immediately removed and evaluated for 
cause of death. With the exception of weight gain and survival, which were monitored on a weekly and 
daily basis, respectively, all other parameters were evaluated at the end of 7 weeks. 
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Table 6. Ingredient and proximate composition of experimental diets (g/100 g of dry weight). 
Level of AFB1 (ppm) 0 0.1 0.25 0.5 1 2 3 5 5 5 
Level of NS (%) 0 0 0 0 0 0 0 0 1 2 
Menhaden Meal a 34.9 34.9 34.9 34.9 34.9 34.9 34.9 34.9 34.9 34.9 
Soybean Meal b 27.3 27.3 27.3 27.3 27.3 27.3 27.3 27.3 27.3 27.3 
Dextrinized Starch c 16.0 16.5 16.5 16.5 16.5 16.5 16.5 16.5 16.5 16.5 
Menhaden Oil a 5.6 5.6 5.6 5.6 5.6 5.6 5.6 5.6 5.6 5.6 
Vitamin Premix d 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Mineral Premix c 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 4.0 
CMC c 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 
Glycine e 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Lysine e 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
NS f 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.3 
AFB1-spiked Celufil g 0.0 0.2 0.7 1.6 4.5 0.5 0.8 1.6 1.6 1.6 
Celufil e 5.5 5.3 4.8 3.9 1.0 5.0 4.7 3.9 2.8 1.7 
Proximate Composition  
(% dry matter) 
          
Protein 36.2 35.8 35.7 35.2 35.6 35.5 36.1 35.6 35.2 35.5 
Lipid 9.5 9.3 10.3 10.4 10.7 10.6 10.6 10.7 10.7 11.1 
Dry Matter 94.5 94.7 94.9 93.6 94.3 94.8 95.2 95.4 95.4 95.0 
Ash 11.1 10.9 10.9 11.3 11.1 10.9 10.9 11.1 11.8 12.9 
a Special Select, Omega Protein, Houston, TX, USA; b De-hulled, roasted/cooked and solvent extracted, 
Producers Cooperative Association, Bryan, TX; c MP Biomedicals LLC, Solon, OH; d Contains (as g kg−1): 
Ca(C6H10O6)·5H2O, 348.49; Ca(H2PO4)·2H2O, 136.0; FeSO4·7H2O, 5.0; MgSO4·7H2O, 132.0; K2HPO4, 
240.0; NaH2PO4·H2O, 88.0; NaCl, 45.0; AlCl3 6H2O, 0.15; KI, 0.15; CuSO4·5H2O, 0.5; MnSO4·H2O, 0.7; 
CoCl2·6H2O, 1.0; ZnSO4·7H2O, 3.0; Na2SeO3, 0.011; e USB Corporation, Cleveland, OH; f Englehard 
Corporation, Jackson, MS; g Sigma-Aldrich, St. Louis, MO, USA. 
4.3. Fish Growth and Health Responses 
Weight gain (% of initial weight), feed efficiency (g weight gain/g dry diet fed), and survival rate 
(% per treatment group) were calculated at the end of the trial. Two fish were sampled from each 
aquaria and homogenized together using a blender. Whole-body analysis was performed by evaluating 
moisture, ash, protein and lipid content according to previously established procedures [55]. Somatic 
indexes including spleen, liver (HSI), intraperitoneal (IPF) fat and muscle (MSI) were averaged based 
on 2 fish per aquaria (n = 6). Each somatic index was calculated as follows: (organ weight/body 
weight) × 100. Only the dextral side of each fish was filleted, weighed, and then doubled to  
obtain MSI. 
4.4. Immunological Responses 
Immunological parameters were evaluated including plasma lysozyme of white blood cell origin, 
neutrophil oxidative radical production in whole blood, and % trypsin inhibition. Two fish were 
randomly selected and bled from each tank, then pooled according to treatment (6 fish per treatment). 
A total of approximately 1–2 mL of blood was collected per treatment group using heparinized 
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syringes. Plasma lysozyme was analyzed by employing a turbidimetric method [56,57]. Blood 
neutrophil oxidative radical production was measured utilizing a nitro blue tetrazolium (NBT)  
assay [56,58]. Plasma was also used to determine % trypsin inhibition according to a previously 
established method [59]. 
4.5. Histological Response 
Livers were dissected from two fish per tank, or six per treatment. Immediately after dissection, 
livers were fixed in 10% formalin overnight. Livers were subsequently rinsed with 70% ethanol 
solution and transferred to vials containing 10 mL fresh 70% ethanol. Samples were processed and 
paraffin embedded within 48 h for routine histopathology at the Texas A&M Veterinary Pathobiology 
Histology Laboratory (College Station, TX, USA). Samples were sectioned at a thickness of 5 µm and 
stained with hematoxylin and eosin (H&E). Lesions were blindly examined and scored according to 
the criteria listed in Table 7. 
Table 7. Histological evaluation criteria. 
Score Evaluation Description 
0 Normal Intracytoplasmic vacuolation, mostly macrovacuolar with one of the 
control livers also having micro and macrovesiculation.  
Nuclei are small and pushed to the periphery with small nucleoli. 
1+ Minimal Scattered increase in nuclear size and mostly inconspicuous nucleoli. 
2+ Mild Mild hypertrophy and pleomorphism with slightly prominent nuclei 
and more evident nucleoli. Some loss of intracytoplasmic 
macrovacuoles, and formation of microvacuoles. 
3+ Moderate Moderate cellular pleomorphism, with anisocytosis, anisokaryosis, 
megalocytosis and megalokaryosis. Sparse intracytoplasmic vacuoles. 
4+ Marked Diffuse loss of cytoplasmic vacuolation, mostly solid cytoplasm. 
Marked pleomorphism, anisocytosis, anisokaryosis,  
megalocytosis and megalokaryosis. 
4.6. Immunohistochemistry 
Immunohistochemistry for proliferating cell nuclear antigen (PCNA) was performed on 
deparaffinized sections of liver mounted on positively charged, silanized slides using an automated 
staining system for immunohistochemistry (Lab Vision Autostainer 360, Runcom, Cheshire, UK). 
Briefly, slides were placed in a heated chamber with DIVA decloaking solution (Biocare Medical 
LLC., Concord, CA, USA) and heated to 121 °C for antigen retrieval. The slides were incubated with a 
1:200 dilution of PCNA (Fisher Scientific, Walther, MA, USA) for 20 min followed by a secondary 
antibody, ImmpRESS (Vector Scientific, Burlingame, CA, USA) for 30 min. The primary antibody 
was omitted on negative control tissues. Slides were then stained with DAB Quanto (Vector Scientific, 
Burlingame, CA, USA) for 5 min, followed by counterstaining with hematoxylin (Biocare Medical 
LLC., Concord, CA, USA) for 1.5 min. Slides were further dehydrated and mounted. Negative and 
positive control tissues were stained together with all fish livers. Canine and mouse small intestine, 
bronchial epithelium and tonsils were used as positive control tissues. All photographs were taken at 
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400× magnification. Stained nuclei were counted, averaged and evaluated for each treatment using 
CellProfiler software [60]. The percentage of PCNA positive cells ((positive/total nuclei) ×100) was 
calculated based on 4 fields/fish × 6 fish/treatment (24 fields/treatment). 
4.7. Statistical Analysis 
All statistics were computed using Statistical Analysis System (SAS) version 9.2 (SAS Institute, 
Cary, NC, USA). Data from groups exposed to 0–5 ppm AFB1 were subject to a general linear model 
regression, while 0 ppm AFB1, 5 ppm AFB1, 5 ppm AFB1 + 1% NS and 5 ppm AFB1 + 2% NS group 
data were subject to an incomplete factorial ANOVA for all parameters except histopathological 
scoring. Histopathological scores were first subject to Aligned Rank Transformation [61] and then 
further analyzed using a general linear model regression or incomplete factorial ANOVA. All 
differences among treatment means were determined using Duncan’s multiple range test. Treatment 
differences were considered significant at p < 0.05. 
5. Conclusions 
These findings indicate that red drum are susceptible to AFB1 in levels as low as 0.1 ppm. Other 
unevaluated species should be tested for AFB1 susceptibility, especially warm-water species raised in 
tropical and subtropical environments where the mycotoxin contamination risk is high. NovaSil 
supplementation at levels between 1%–2% may be used in fish feed safely to effectively reduce AFB1 
toxicity. Therefore, this technology could be used by the aquaculture industry as a strategy to reduce 
aflatoxin-related morbidity and mortality in fish. 
Acknowledgements 
A special thank-you to Brian Ray, Manager of the Aquacultural Research and Teaching Facility, 
Texas A&M University. This research was funded by CONACyT 2010-020 and BASF Corporation 
and was conducted as part of Katherine Zychowski’s Toxicology program through the Texas A&M 
University Veterinary Integrative Biosciences program. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Cardwell, K.F. Mycotoxin Contamination in Foods: Anti-Nutritional Factors. In Proceedings on 
Improving Human Nutrition through Agriculture, Los Banos, CA, USA, 1999; pp. 27–34. 
2. Council for Agricultural Science and Technology (CAST). Mycotoxins: Economic and Health 
Risks; CAST: Ames, IA, USA, 1989. 
3. Mishra, H.N.; Das, C. A review on biological control and metabolism of aflatoxin. Crit. Rev. 
Food Sci. Nutr. 2003, 43, 245–264. 
4. Quist, C.F.; Bounous, D.I.; Kilburn, J.V.; Nettles, V.F.; Wyatt, R.D. The effect of dietary 
aflatoxin on wild Turkey poults. J. Wildlife Dis. 2000, 36, 436–444. 
Toxins 2013, 5 1570 
 
 
5. Florentin, E.R.; Cottier, G.J.; Diener, U.L.; Davis, N.D. Effect of aflatoxin on different breeds and 
crosses of chickens. Poult. Sci. 1969, 48, 1807. 
6. Jiang, Y.; Jolly, P.E.; Ellis, W.O.; Wang, J.S.; Phillips, T.D.; Williams, J.H. Aflatoxin B1 albumin 
adduct levels and cellular immune status in Ghanaians. Int. Immunol. 2005, 17, 807–814. 
7. Bostock, J.; McAndrew, B.; Richards, R.; Jauncey, K.; Telfer, T.; Lorenzen, K.; Little, D.; Ross, L.; 
Handisyde, N.; Gatward, I. Aquaculture: Global status and trends. Philos. Trans. R. Soc. B 2010, 
365, 2897–2912. 
8. Bimbo, A.P.; Crowther, J.B. Fish meal and oil: Current uses. J. Am. Oil Chem. Soc. 1992, 69, 
221–227. 
9. Pauly, D. The most important fish in the sea—Menhaden and America. Science 2007, 318,  
750–751. 
10. Davis, D.A.; Jirsa, D.; Arnold, C. Evaluation of soybean proteins as replacements for menhaden 
fish meal in practical diets for the red drum Sciaenops ocellatus. J. World Aquac. Soc. 1995, 26, 
48–58. 
11. Yue, Y.R.; Liu, Y.J.; Tian, L.X.; Gan, L.; Yang, H.J.; Liang, G.Y. Effects of replacing fish meal 
with soybean meal and peanut meal on growth, feed utilization and haemolymph indexes for 
juvenile white shrimp Litopenaeus vannamei, Boone. Aquac. Res. 2012, 43, 1687–1696. 
12. Li, M.H.; Robinson, E.H.; Oberle, D.F.; Lucas, P.M.; Bosworth, B.G. Evaluation of corn gluten 
feed and cottonseed meal as partial replacements for soybean meal and corn in diets for  
pond-raised hybrid catfish, Ictalurus punctatus X I. furcatus. J. World Aquac. Soc. 2012, 43,  
107–113. 
13. Naylor, R.L.; Hardy, R.W.; Bureau, D.P.; Chiu, A.; Elliott, M.; Farrell, A.P.; Forster, I.;  
Gatlin, D.M.; Goldburg, R.J.; Hua, K.; et al. Feeding aquaculture in an era of finite resources. 
Proc.Natl. Acad. Sci. USA 2009, 106, 15103–15110, 18040, doi:10.1073/pnas.0905235106. 
14. Bautista, M.N.; Lavillapitogo, C.R.; Subosa, P.F.; Begino, E.T. Aflatoxin B-1 contamination of 
shrimp feeds and its effect on growth and hepatopancreas of pre-adult Penaeus monodon. J. Sci. 
Food Agric. 1994, 65, 5–11. 
15. Abdelhamid, A.M.; Khalil, F.F.; Ragab, M.A. Problem of mycotoxins in fish production. Egyp. J. 
Nutr. Feeds 1998, 1, 63–71. 
16. Barbosa, T.; Pereyra, C.; Soleiro, C.; Dias, E.; Oliveira, A.; Keller, K.; Silva, P.; Cavaglieri, L.; 
Rosa, C. Mycobiota and mycotoxins present in finished fish feeds from farms in the Rio de 
Janeiro State, Brazil. Int. Aquat. Res. 2013, 5, 1–9. 
17. Phillips, T.; Afriyie-Gyawu, E.; Williams, J.; Huebner, H.; Ankrah, N.A.; Ofori-Adjei, D.;  
Jolly, P.; Johnson, N.; Taylor, J.; Marroquin-Cardona, A. Reducing human exposure to aflatoxin 
through the use of clay: A review. Food Addit. Contam. 2008, 25, 134–145. 
18. Grant, P.G.; Phillips, T.D. Isothermal adsorption of aflatoxin B-1 on hscas clay. J. Agric. Food 
Chem. 1998, 46, 599–605. 
19. Marroquín-Cardona, A.; Deng, Y.; Garcia-Mazcorro, J.; Johnson, N.; Mitchell, N.; Tang, L.; 
Robinson, A.; Taylor, J.; Wang, J.S.; Phillips, T. Characterization and safety of uniform particle 
size NovaSil clay as a potential aflatoxin enterosorbent. Appl. Clay Sci. 2011, 54, 248–257. 
Toxins 2013, 5 1571 
 
 
20. Afriyie-Gyawu, E.; Mackie, J.; Dash, B.; Wiles, M.; Taylor, J.; Huebner, H.; Tang, L.L.;  
Guan, H.X.; Wang, J.S.; Phillips, T. Chronic toxicological evaluation of dietary NovaSil clay in 
Sprague-Dawley rats. Food Addit. Contam. 2005, 22, 259–269. 
21. Mayura, K.; Abdel-Wahhab, M.A.; McKenzie, K.S.; Sarr, A.B.; Edwards, J.F.; Naguib, K.; 
Phillips, T.D. Prevention of maternal and developmental toxicity in rats via dietary inclusion of 
common aflatoxin sorbents: Potential for hidden risks. Toxicol. Sci. 1998, 41, 175–182. 
22. Zychowski, K.E.; Pohlenz, C.; Mays, T.; Romoser, A.; Hume, M.; Buentello, A.; Gatlin Iii, D.M.; 
Phillips, T.D. The effect of NovaSil dietary supplementation on the growth and health 
performance of Nile tilapia (Oreochromis niloticus) fed aflatoxin-B1 contaminated feed. 
Aquaculture 2013, 376–379, 117–123. 
23. Peters, K.M.; McMichael, R.H., Jr. Early life history of the red drum, Sciaenops ocellatus (Pisces: 
Sciaenidae), in Tampa Bay, Florida. Estuaries 1987, 10, 92–107. 
24. Food and Agriculture Organization (FAO). Cultured Aquatic Species Information Programme: 
Sciaenops ocellatus. Available online: http://www.fao.org/fishery/en (accessed on 2 May 2013). 
25. Ellis, S.C.; Reigh, R.C. Effects of dietary lipid and carbohydrate levels on growth and body 
composition of juvenile red drum, Sciaenops ocellatus. Aquaculture 1991, 97, 383–394. 
26. McGoogan, B.; Gatlin, D. Effects of replacing fish meal with soybean meal in diets for red drum 
sciaenops ocellatus and potential for palatability enhancement. J. World Aquac. Soc. 1997, 28, 
374–385. 
27. Panangala, V.S.; Giambrone, J.J.; Diener, U.L.; Davis, N.D.; Hoerr, F.J.; Mitra, A.; Schultz, R.D.; 
Wilt, G.R. Effects of aflatoxin on the growth performance and immune responses of weanling 
swine. Am. J. Vet. Res. 1986, 47, 2062–2067. 
28. Dalvi, R. An overview of aflatoxicosis of poultry: Its characteristics, prevention and reduction. 
Vet. Res. Commun. 1986, 10, 429–443. 
29. Deng, S.X.; Tian, L.X.; Liu, F.J.; Jin, S.J.; Liang, G.Y.; Yang, H.J.; Du, Z.Y.; Liu, Y.J. Toxic 
effects and residue of aflatoxin B1 in tilapia (Oreochromis niloticus × O. aureus) during  
long-term dietary exposure. Aquaculture 2010, 307, 233–240. 
30. Anh Tuan, N.; Grizzle, J.M.; Lovell, R.T.; Manning, B.B.; Rottinghaus, G.E. Growth and hepatic 
lesions of Nile Tilapia (Oreochromis niloticus) fed diets containing aflatoxin B1. Aquaculture 
2002, 212, 311–319. 
31. Santacroce, M.P.; Conversano, M.; Casalino, E.; Lai, O.; Zizzadoro, C.; Centoducati, G.; 
Crescenzo, G. Aflatoxins in aquatic species: Metabolism, toxicity and perspectives. Rev. Fish 
Biol. Fish. 2008, 18, 99–130. 
32. Han, D.; Xie, S.; Zhu, X.; Yang, Y.; Guo, Z. Growth and hepatopancreas performances of gibel 
carp fed diets containing low levels of aflatoxin B1. Aquac. Nutr. 2010, 16, 335–342. 
33. Raghavan, P.R.; Zhu, X.; Lei, W.; Han, D.; Yang, Y.; Xie, S. Low levels of Aflatoxin B1 could 
cause mortalities in juvenile hybrid sturgeon, Acipenser ruthenus ♂×A. baeri♀. Aquac. Nutr. 
2011, 17, e39–e47. 
34. Cagauan, A.G.; Tayaban, R.H.; Somga, J.R.; Bartolome, R.M. Effect of Aflatoxin-Contaminated 
Feeds in Nile Tilapia (Oreochromis Niloticus L.). In Proceedings of 6th International Symposium 
on Tilapia in Aquaculture (ISTA 6) Section: Health Management and Diseases, Manila, 
Philippines, 2004. 
Toxins 2013, 5 1572 
 
 
35. Calabrese, E.J. Hormetic dose-response relationships in immunology: Occurrence, quantitative 
features of the dose response, mechanistic foundations, and clinical implications. Crit. Rev. 
Toxicol. 2005, 35, 89–295. 
36. Calabrese, E.J. Hormesis: A revolution in toxicology, risk assessment and medicine. EMBO Rep. 
2004, 5, S37–S40. 
37. Diaz, G.; Calabrese, E.; Blain, R. Aflatoxicosis in chickens (Gallus gallus): An example of 
hormesis? Poult. Sci. 2008, 87, 727–732. 
38. Chávez-Sánchez, M.C.; Martínez Palacios, C.A.; Osorio Moreno, I. Pathological effects of 
feeding young Oreochromis niloticus diets supplemented with different levels of aflatoxin B1. 
Aquaculture 1994, 127, 49–60. 
39. Ostrander, G.K.; Blair, J.B.; Stark, B.A.; Marley, G.M.; Bales, W.D.; Veltri, R.W.; Hinton, D.E.; 
Okihiro, M.; Ortego, L.S.; Hawkins, W.E. Long-term primary culture of epithelial cells from 
rainbow trout (Oncorhynchus mykiss) liver. In Vitro Cell. Dev. Biol. Anim. 1995, 31, 367–378. 
40. Borucinska, J.D.; Schmidt, B.; Tolisano, J.; Woodward, D. Molecular markers of cancer in 
cartilaginous fish: Immunocytochemical study of PCNA, p-53, myc and ras expression in 
neoplastic and hyperplastic tissues from free ranging blue sharks, Prionace glauca (L.). J. Fish 
Dis. 2008, 31, 107–115. 
41. Banlunara, W.; Bintvihok, A.; Kumagai, S. Immunohistochemical study of proliferating cell 
nuclear antigen (PCNA) in duckling liver fed with aflatoxin B1 and esterified glucomannan. 
Toxicon 2005, 46, 954–957. 
42. Oznurlu, Y.; Celik, I.; Sur, E.; Ozaydin, T.; Oguz, H.; Altunbas, K. Determination of the effects 
of aflatoxin B-1 given in ovo on the proximal tibial growth plate of broiler chickens: Histological, 
histometric and immunohistochemical findings. Avian Pathol. 2012, 41, 469–477. 
43. Bailey, G.S.; Williams, D.E.; Wilcox, J.S.; Loveland, P.M.; Coulombe, R.A.; Hendricks, J.D. 
Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in 
sensitive and resistant salmonid fish. Carcinogenesis 1988, 9, 1919–1926. 
44. Mohapatra, S.; Sahu, N.P.; Pal, A.K.; Prusty, A.K.; Kumar, V.; Kumar, S. Haemato-immunology 
and histo-architectural changes in Labeo rohita fingerlings: Effect of dietary aflatoxin and mould 
inhibitor. Fish Physiol. Biochem. 2011, 37, 177–186. 
45. Hassan, A.M.; Kenawy, A.M.; Abbas, W.T.; Abdel-Wahhab, M.A. Prevention of cytogenetic, 
histochemical and biochemical alterations in Oreochromis niloticus by dietary supplement of 
sorbent materials. Ecotoxicol. Environ. Saf. 2010, 73, 1890–1895. 
46. Hamilton, P.; Garlich, J. Aflatoxin as a possible cause of fatty liver syndrome in laying hens. 
Poult. Sci. 1971, 50, 800–804. 
47. Rogers, A.E.; Newberne, P.M. Diet and aflatoxin B1 toxicity in rats. Toxicol. Appl. Pharmacol. 
1971, 20, 113–121. 
48. Tucker, J.W., Jr.; Lellis, W.A.; Vermeer, G.K.; Roberts, D.E., Jr.; Woodward, P.N. The effects of 
experimental starter diets with different levels of soybean or menhaden oil on red drum 
(Sciaenops ocellatus). Aquaculture 1997, 149, 323–339. 
49. Karaman, M.; Ozen, H.; Tuzcu, M.; Cigremis, Y.; Onder, F.; Ozcan, K. Pathological, biochemical 
and haematological investigations on the protective effect of α-lipoic acid in experimental 
aflatoxin toxicosis in chicks. Br. Poult. Sci. 2010, 51, 132–141. 
Toxins 2013, 5 1573 
 
 
50. Godlewski, C.E.; Boyd, J.N.; Sherman, W.K.; Anderson, J.L.; Stoewsand, G.S. Hepatic 
glutathione S-transferase activity and aflatoxin B1-induced enzyme altered foci in rats fed 
fractions of brussels sprouts. Cancer Lett. 1985, 28, 151–157. 
51. Hanigan, M.H.; Pitot, H.C. Gamma-glutamyl transpeptidase—Its role in hepatocarcinogenesis. 
Carcinogenesis 1985, 6, 165–172. 
52. Ellis, R.; Clements, M.; Tibbetts, A.; Winfree, R. Reduction of the bioavailability of 20 μg/kg 
aflatoxin in trout feed containing clay. Aquaculture 2000, 183, 179–188. 
53. Eya, J.C.; Parsons, A.; Haile, I.; Jagidi, P. Effects of dietary zeolites (bentonite and mordenite) on 
the performance juvenile rainbow trout onchorhynchus myskis. Austr. J. Basic Appl. Sci. 2008, 2, 
961–967. 
54. Gatlin, D.M. Red Drum Sciaenops Ocellatus. In Nutrient Requirements and Feeding of Fish for 
Aquaculture; Webster, C.D., Lim, C., Eds.; CABI Publishing: Wallingford, Oxon, UK, 2002;  
pp. 147–158. 
55. Webb, K.A.; Gatlin, D.M. Effects of dietary protein level and form on production characteristics 
and ammonia excretion of red drum sciaenops ocellatus. Aquaculture 2003, 225, 17–26. 
56. Li, P.; Gatlin, D.M. Evaluation of brewers yeast (Saccharomyces cerevisiae) as a feed supplement 
for hybrid striped bass (Morone chrysops × M-saxatilis). Aquaculture 2003, 219, 681–692. 
57. Jorgensen, J.B.; Sharp, G.J.E.; Secombes, C.J.; Robertsen, B. Effect of a yeast-cell-wall glucan on 
the bactericidal activity of rainbow-trout macrophages. Fish Shellfish Immunol. 1993, 3, 267–277. 
58. Siwicki, A.K.; Anderson, D.P.; Rumsey, G.L. Dietary intake of immunostimulants by rainbow 
trout affects nonspecific immunity and protection against furunculosis. Vet. Immunol. 
Immunopathol. 1994, 41, 125–139. 
59. Lange, S.; Guđmundsdottir, B.K.; Magnadottir, B. Humoral immune parameters of cultured 
atlantic halibut (Hippoglossus Hippoglossus). Fish Shellfish Immunol. 2001, 11, 523–535. 
60. Lamprecht, M.R.; Sabatini, D.M.; Carpenter, A.E. Cellprofiler™: Free, versatile software for 
automated biological image analysis. Biotechniques 2007, 42, 71. 
61. Wobbrock, J.O.; Findlater, L.; Gergle, D.; Higgins, J.J. The Aligned Rank Transform for 
Nonparametric Factorial Analyses Using Only Anova Procedures. In Proceedings of the ACM 
Conference on Human Factors in Computing Systems (CHI '11), Vancouver, Canada, 7–12 May 
2011; pp. 143–146. 
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
